S
Suzanne V. Arnold
Researcher at University of Missouri–Kansas City
Publications - 244
Citations - 7512
Suzanne V. Arnold is an academic researcher from University of Missouri–Kansas City. The author has contributed to research in topics: Angina & Medicine. The author has an hindex of 43, co-authored 212 publications receiving 5511 citations. Previous affiliations of Suzanne V. Arnold include Lahey Hospital & Medical Center & Children's Mercy Hospital.
Papers
More filters
Journal ArticleDOI
Cardiovascular Outcomes and Mortality in Type 2 Diabetes with Associated Cardio-Renal-Metabolic Comorbidities
Suzanne V. Arnold,Phillip R. Hunt,Hungta Chen,Sharon Maclachlan,Enrico Repetto,Jiten Vora,Mikhail Kosiborod +6 more
TL;DR: In patients with new diagnosis of T2DM, the risk of MACE, HF, and death increased incrementally with a greater number of CRMCs; with CKD being the main driver of mortality.
Journal ArticleDOI
Relation of Frailty to Outcomes After Transcatheter Aortic Valve Replacement (from the PARTNER Trial)
Philip Green,Suzanne V. Arnold,David Cohen,Ajay J. Kirtane,Susheel Kodali,David L. Brown,Charanjit S. Rihal,Ke Xu,Yang Lei,Marian Hawkey,Rebeca J. Kim,Maria Alu,Martin B. Leon,Michael J. Mack +13 more
TL;DR: Evaluating the prognostic value of frailty in older recipients of TAVR found that frail patients would experience a higher mortality rate and a higher likelihood of poor outcome 1 year after T AVR.
Journal ArticleDOI
Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial
Suzanne V. Arnold,Matthew R. Reynolds,Yang Lei,Elizabeth A. Magnuson,Ajay J. Kirtane,Susheel Kodali,Alan Zajarias,Vinod H. Thourani,Philip Green,Josep Rodés-Cabau,Nirat Beohar,Michael J. Mack,Martin B. Leon,David J. Cohen +13 more
TL;DR: Predictive models that can identify patients at high risk for a poor outcome after TAVR are developed and validated and may help guide treatment choices and offer patients realistic expectations of outcomes based on their presenting characteristics.
Journal ArticleDOI
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review.
TL;DR: How to interpret the Kansas City Cardiomyopathy Questionnaire, how it should be analyzed in clinical trials to maximize the interpretability of results, and how it can be used in clinical practice and population health are described.
Journal ArticleDOI
Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the TERISA Randomized Clinical Trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)
Mikhail Kosiborod,Suzanne V. Arnold,John A. Spertus,Darren K. McGuire,Yan Li,Patrick Yue,Ori Ben-Yehuda,Amos Katz,Philip G. Jones,Ann Olmsted,Luiz Belardinelli,Bernard R. Chaitman +11 more
TL;DR: In this article, the efficacy of ranolazine versus placebo on weekly angina frequency and sublingual nitroglycerin use in subjects with type 2 diabetes mellitus, coronary ar...